AXL and B-cell acute lymphoblastic leukemia: Previously, we have demonstrated that dexamethasone-resistant B-cell acute lymphoblastic leukemia cells that express the oncogenic mutant of FLT3 display upregulation of AXL expression upon inhibition of FLT3 [44].